Additionally, the serum levels of ITGβ-1 in HGGs were greater than those in LGGs, suggesting that ITGβ-1 together with galectins, especially GAL-3 and − 8, can be evaluated as a predictor of glioma severity. This evidence concerns the gene ITGB1 and central nervous system cancer.